Tim Waterboer

Plain English
This study looked at how infections that a mother has in the first trimester of pregnancy might affect the heart health of their babies. Researchers found that these infections increased the risk of congenital heart defects (CHD) by 63%. Specifically, infections like rubella and respiratory viruses were linked to even higher risks, with rubella increasing the risk by 178%. Understanding this link is important because it can help healthcare providers identify pregnancies at higher risk for heart defects and guide monitoring and treatment. Who this helps: This helps pregnant women and their doctors.

Plain English
This study looked at how the body reacts to antibodies from the Epstein-Barr virus (EBV) in people with nasopharyngeal carcinoma (NPC), a type of cancer associated with this virus. Researchers tested blood samples from 98 NPC patients and 142 healthy individuals to see if antibody patterns could help identify the disease. They found that specific antibody tests could accurately detect EBV-positive NPC in both areas where the cancer is common and where it is rare, with an accuracy rate between 90% and 99%. Who this helps: This benefits doctors and researchers trying to diagnose and understand nasopharyngeal carcinoma more effectively.

Plain English
This study looked at how the body's immune response to certain proteins from a type of bacteria called Fusobacterium might relate to survival rates in colorectal cancer patients. Researchers analyzed blood from 471 patients who were diagnosed with colorectal cancer, finding that while there was no overall link between antibody responses and cancer death for most patients, those diagnosed at a younger age showed a significant association. Specifically, patients who had antibodies to one particular Fusobacterium protein had a much higher risk of dying from their cancer (7 times more likely). Who this helps: This research could benefit younger colorectal cancer patients by providing insights into their risk factors.

Plain English
This study looked at a quick test that checks for HPV16-L1 antibodies to see if it can diagnose oropharyngeal cancer (a type of throat cancer linked to HPV). The test showed a low success rate, with only 25% of cancer cases correctly identified (sensitivity) while being very accurate in saying someone doesn’t have cancer (97.1% specificity). This matters because it highlights that the test is not reliable for screening this type of cancer, which could lead to unnecessary worry or missed diagnoses. Who this helps: This helps doctors and patients understand the limitations of current testing methods for oropharyngeal cancer.

Plain English
This study looked at the presence of Helicobacter pylori (Hp), a type of bacteria, in patients with autoimmune atrophic gastritis (AAG) who tested negative for the bacteria in tissue samples. Among 178 adults, those with AAG showed an average response to 2.2 Hp antigens, higher than healthy individuals (1.4) but lower than those with Hp-positive gastritis (5.4). This is important because it shows that some AAG patients may have been exposed to Hp, suggesting that the infection might help trigger their condition. Who this helps: This research helps patients with autoimmune atrophic gastritis and their doctors understand the role of Hp in their disease.

Plain English
This study looked at how infections from 18 viruses, bacteria, and protozoa relate to frailty and dying among middle-aged and older adults in the UK. It found that past infections with Toxoplasma gondii and Helicobacter pylori were linked to increased frailty, which is equivalent to aging 3.8 and 3.1 years, respectively. The research suggests that these infections can worsen the health of older people, indicating the need for better prevention and treatment strategies. Who this helps: Older adults and healthcare providers managing age-related health issues.

Plain English
This study looked at a protein called LFA-1 and how it affects the immune system's ability to monitor and respond to skin infections caused by certain viruses. Researchers found that people lacking LFA-1 had no history of serious infections but experienced skin problems due to these viruses; specifically, these individuals had difficulty with immune cells called T cells moving to the skin, resulting in an accumulation of these cells in the bloodstream. This matters because it highlights the importance of LFA-1 in directing T cells to the skin to fight off specific infections, which could lead to better understanding and treatment for skin-related health issues. Who this helps: This helps patients with skin lesions caused by papillomaviruses and their healthcare providers.

Plain English
The study looked at how specific antibodies related to the Epstein-Barr virus (EBV) vary in patients with nasopharyngeal carcinoma (NPC), a type of cancer linked to EBV. It involved analyzing samples from 353 people, including NPC patients and their families, and found that NPC patients had higher levels of certain antibodies and immune responses compared to healthy individuals. This is important because it helps identify potential early markers for NPC and could lead to better ways to monitor and treat the disease. Who this helps: This benefits patients at risk for nasopharyngeal carcinoma and their doctors.

Plain English
This study looked at the link between human herpesvirus 7 and the risk of developing multiple sclerosis (MS). Researchers found that people who had evidence of human herpesvirus 7 were more than twice as likely to develop MS compared to those who didn’t, with an odds ratio of 2.2. This is important because it helps identify potential risk factors for MS, which could lead to better prevention or treatment strategies. Who this helps: This benefits researchers and healthcare professionals seeking to understand and address the risk factors for multiple sclerosis.

Plain English
This study looked at factors that might increase the risk of a rare type of nose and throat cancer linked to the human papillomavirus (HPV) and those not linked to HPV. Researchers found that 45.8% of patients with HPV-related cancers had antibodies to the virus, while none of the other cancer patients or controls had these antibodies. The study also discovered that having your tonsils removed was associated with a lower risk of developing HPV-related cancer. Who this helps: This information benefits patients and doctors by highlighting risk factors for sinonasal cancer and informing prevention strategies.

Plain English
Researchers developed a blood test that detects HPV cancer DNA years before oropharyngeal cancer (a common throat cancer) develops, finding the virus DNA in 79% of patient blood samples taken up to 7.8 years before diagnosis, while showing no false positives in healthy people. Using advanced computer analysis, they improved the test to detect the cancer signal in 96% of cases up to 10 years before symptoms appear. This discovery could enable doctors to catch this aggressive cancer much earlier, when treatment is more likely to succeed and causes less harm.

Plain English
This study looked at how natural immunity to human papillomavirus (HPV) affects the chances of getting infected among heterosexual couples. The researchers followed 392 couples and found that having higher levels of HPV antibodies in one partner did not significantly reduce the risk of HPV infections in the other partner—females had a hazard ratio of 1.05 and males had an odds ratio of 1.31. This matters because it highlights that natural immunity against HPV might not be enough to prevent infection between sexual partners. Who this helps: This information is useful for patients, particularly those concerned about HPV transmission.

Plain English
This study focused on understanding how human papillomavirus (HPV) infections behave in young women, particularly why about 10% of infections persist longer than expected. Researchers followed 189 women aged 18 to 25 over four years, finding that HPV viral load levels stabilize within two months after infection and then clear rapidly after about 13 to 20 months for those infections that don’t persist. The findings highlight important immune factors, such as specific immune cells and cytokines, that could lead to better treatments and preventive measures against HPV-associated diseases. Who this helps: This helps women at risk of HPV infections and healthcare providers focusing on cervical health.

Plain English
Researchers studied oral HPV (human papillomavirus) in healthy adults aged 18-60 in dental clinics across France, Germany, Spain, the UK, and the US from late 2020 to mid-2023. They found that about 6.6% to 15.0% of men and 3.6% to 6.8% of women had any oral HPV, with higher rates of high-risk HPV types among men (1.8% to 4.5%) and women (0.2% to 2.1%). This is important because certain types of HPV are linked to throat cancer, particularly in older men. Who this helps: Patients who may be at risk for HPV-related health issues.

Plain English
This study looked at how well different methods detect oral infections caused by human papillomavirus (HPV), particularly in patients undergoing tonsil surgery. Researchers tested samples from 945 people and found that while oral rinses detected the most infections (4% for high-risk HPV), they still missed a significant number (73%) that were found using other methods, such as tissue samples. Understanding these detection rates is important for developing effective vaccination and screening programs. Who this helps: This helps healthcare providers and public health officials improve HPV detection and inform vaccination strategies.

Plain English
Researchers studied how different factors like sex, age, and previous infections affect people's immune responses to the yellow fever vaccine. They found that having certain types of T cells in the body before vaccination could predict how well someone responds to the vaccine. Specifically, higher levels of specific immune cells led to stronger responses, while certain conditions like being infected with cytomegalovirus resulted in weaker responses in some males. Who this helps: This information benefits vaccine researchers and healthcare providers by helping them understand who may respond better to the yellow fever vaccine.

Plain English
This study looked at how different ways of measuring smoking impact the survival of patients with a type of throat cancer called head and neck squamous cell carcinoma (HNSCC). Researchers analyzed data from nearly 8,900 patients and found that two specific measures—how long someone has smoked and a calculation based on their daily smoking habits—were better at predicting survival than the more commonly used pack-years measurement. For example, each additional year of smoking was linked to a 11% increase in the risk of death from cancer. Who this helps: This information benefits doctors and researchers by providing better tools to assess and communicate cancer risks to patients.

Plain English
The VOYAGER study looked at how human papillomavirus (HPV) and genetic factors affect the risk and survival of oral and throat cancers. Researchers gathered data from more than 10,000 people, including 7,233 with cancer and 3,297 without, to understand how these factors influence cancer outcomes. Their findings will help improve prevention, early detection, and treatment strategies for head and neck cancer, which is a significant global health concern. Who this helps: This benefits patients with head and neck cancer and their healthcare providers.

Plain English
This study looked at patients with a type of throat cancer caused by the human papillomavirus (HPV) and explored a new method for monitoring their health after treatment. Researchers found that testing for HPV DNA in the blood was very effective: it correctly identified 100% of patients who had a recurrence of cancer within a year, and it also missed only 2% of patients who did not have a recurrence. This is important because catching cancer recurrence early can help improve treatment and health outcomes for patients. Who this helps: Patients recovering from HPV-related throat cancer.

Plain English
The study investigated how the immune system responds to the COVID-19 virus in terms of antibody production among people in Costa Rica who were infected, looking at samples taken from 794 unvaccinated individuals over various time periods. It found that 96% of participants had antibodies to the virus just weeks after infection, but this response varied over time: while nearly all had protective antibodies shortly after infection, only 42% maintained a specific type of antibody a year later. The research showed that men, older individuals, and those with more severe disease had stronger antibody responses, highlighting the importance of understanding these factors in fighting COVID-19. Who this helps: This helps patients and doctors understand how long immune protection lasts after infection and identify which groups may need more attention.

Plain English
This study looked at the genetic factors that contribute to breast cancer risk in Black women from South Africa by comparing 2,485 breast cancer patients to 1,101 healthy individuals. The researchers found two specific genetic markers linked to an increased risk of breast cancer. This is important because it highlights unique genetic differences in African populations, which may lead to better-targeted prevention and treatment strategies specific to these groups. Who this helps: This helps patients, particularly Black women in South Africa, by identifying risk factors that could improve screening and treatment.

Plain English
This research study looked at why certain groups of people were more likely to test positive for COVID-19. It found that older adults and those with higher income were less likely to have antibodies indicating past infection, while people with obesity and larger households were more likely to test positive. Understanding these patterns is important for accurately identifying who is at risk and ensuring effective public health responses. Who this helps: This helps public health officials and researchers better target prevention efforts and testing resources.

Plain English
This study looked at the presence of two harmful proteins, CagA and VacA, in healthy adults from Honduras and Guatemala, as these are linked to a higher risk of stomach cancer. The researchers found that 87% of participants had antibodies indicating active infection, with 82% showing the CagA protein and 75% the VacA protein. These high rates suggest a significant cancer risk in the region, making it crucial to develop effective health programs to prevent gastric cancer. Who this helps: This helps patients at risk of gastric cancer and healthcare providers in Northern Central America.

Plain English
This study created guidelines for diagnosing and treating oropharyngeal and hypopharyngeal cancers. Oropharyngeal cancer rates have surged over the past 20 years, particularly among men, making it the sixth most common cancer in that group in Germany. Approximately 35% of these cancers are linked to the human papillomavirus (HPV16), and the guidelines recommend a range of treatments, including surgery, radiation, chemotherapy, and rehabilitation to help manage the disease effectively. Who this helps: This benefits patients with head and neck cancers, their doctors, and healthcare providers involved in their care.

Plain English
This study looked at how common oral human papillomavirus (HPV) is among healthy adults in the United States and Europe. Researchers found that the overall prevalence of oral HPV was 1.9% in the U.S. and 3.7% in Europe, with specific types of HPV detected in those populations. Understanding the prevalence of oral HPV is important because it helps assess the risk of developing related health issues, including some cancers. Who this helps: This information benefits patients and healthcare providers by informing them about the risks associated with oral HPV.

Plain English
This research studied how to improve tests for detecting Helicobacter pylori (H. pylori), a bacteria linked to stomach cancer. The team developed new methods to translate detailed test results from a high-tech blood test into clear probabilities of infection. They found that their models were very accurate, achieving at least 95% accuracy in identifying H. pylori infections compared to traditional tests. Who this helps: This helps doctors and researchers diagnose H. pylori infections more effectively, potentially leading to better prevention of gastric cancer for patients.

Plain English
This study compared two HPV vaccines: Cervarix and Gardasil-4, focusing on how well they create antibodies that protect against various strains of the virus. The researchers found that girls who received Cervarix had stronger antibody responses, with 50% higher levels of cross-neutralizing antibodies than those who got Gardasil-4. These results are important because they suggest that Cervarix may offer better protection against multiple HPV types, potentially reducing the risk of cervical cancer. Who this helps: This benefits patients, particularly girls receiving HPV vaccinations, by potentially providing more effective protection against HPV-related diseases.

Plain English
This study looked at the risk of certain throat cancers (specifically tonsillar and base-of-tongue cancers) in husbands of women who had cancers linked to the human papillomavirus (HPV), such as anal, vulvar, and cervical cancers. Researchers found that the risk for these throat cancers was more than five times higher in husbands of women with these cancers during recent years, especially for those diagnosed before age 50. This finding highlights a connection between HPV-related cancers in partners, suggesting that spouses may share an increased risk of developing similar cancers. Who this helps: This helps patients and their partners by raising awareness about the potential risks of HPV-related cancers.

Plain English
This study looked at how antibody levels and their ability to neutralize the SARS-CoV-2 virus change with different types of exposures, like infections and vaccinations. The researchers found that a single vaccine dose was less effective than natural infection, but that two vaccine doses after infection created even higher antibody levels. They also found that while antibody levels may stop rising after the second exposure, the ability to neutralize the virus continues to improve with a third exposure. Who this helps: This information benefits patients by showing them the importance of vaccination, especially after a COVID infection.

Plain English
This study looked at genetic factors that influence head and neck cancers, which can occur in areas like the mouth and throat. Researchers examined over 19,000 patients with cancer and 38,000 healthy individuals from different backgrounds and found 29 new genetic variants that are linked to these cancers, including one variant that reduces overall cancer risk by 40%. Understanding these genetic risks and how they interact with factors like smoking and HPV can help improve prevention and treatment strategies for these cancers. Who this helps: This research benefits patients at risk for head and neck cancers and their doctors.

Plain English
This study looked at whether common genital infections are linked to endometrial cancer. Researchers analyzed blood samples from 443 women with endometrial cancer and 443 women without it, finding that infection with Herpes simplex virus 2 might increase the risk of low-grade tumors by 43%. They also found some evidence suggesting that infections from Chlamydia trachomatis could be a risk factor for type II endometrial cancers, even though the results were not always statistically significant. Who this helps: This research benefits women at risk for endometrial cancer and healthcare providers who are looking for risk factors to improve screening and prevention strategies.

Plain English
This study looked at the presence of antibodies against the HPV-16 E6 protein in nearly 4,000 cancer-free men across Brazil, Mexico, and the United States. Out of these men, only 14 (or 0.35%) tested positive for these antibodies, with older men (ages 50-84) being significantly more likely to test positive compared to younger men (ages 18-29). The findings suggest that while detecting these antibodies is rare, if they are found, they tend to last a long time and could help identify men at risk for oropharyngeal cancer even years before it develops. Who this helps: This research benefits doctors and health professionals who monitor patients for potential cancer risks.

Plain English
This study looked at the long-term presence of specific antibodies in pregnant women and men that indicate prior infections with certain sexually transmitted infections (STIs). The researchers found that 30.4% of women and 17.4% of men had these persistent antibodies, with higher numbers linked to having more sexual partners, engaging in anal sex, and a history of diagnosed STIs. Understanding these risk factors is crucial for developing better prevention and care strategies for STIs. Who this helps: This helps patients at risk for STIs, healthcare providers, and public health officials.

Plain English
This study looked at the presence of specific antibodies, called HPV16 E6, in 2,320 men living with HIV in Tennessee, to find out how common these antibodies are and what factors might be linked to their presence. The researchers found that 5.6% of the men had these antibodies, with a notable portion showing moderate or high levels—2.4% had moderate and 3.2% had high levels. This is important because it highlights a higher prevalence of HPV16 E6 antibodies in this group compared to previous studies, suggesting a greater risk for HPV-related throat cancers, especially in the Southeast U.S., which has high rates of HIV and these cancers. Who this helps: This helps patients living with HIV by providing insight into their risk for HPV-related health issues.

Plain English
This study looked at how Helicobacter pylori (Hp), a bacteria that can cause stomach issues, spreads within families over three years. Researchers tested blood samples from 329 Finnish families and found that 20% of fathers and 10% of mothers had signs of past Hp infection, but very few children (only 0.4-2%) showed any signs of acquiring the bacteria after their mothers' antibodies declined. Importantly, there was no evidence of Hp spreading between family members, suggesting that it does not pass easily from person to person within families. Who this helps: This research benefits doctors and health officials by providing insights into the transmission of Helicobacter pylori, which can inform public health strategies.

Plain English
This study looked at how mothers pass antibodies for the infections Chlamydia trachomatis and Mycoplasma genitalium to their newborns, and how these antibodies change as the child grows in the first three years of life. Researchers followed 309 mother-baby pairs, finding that most mothers transferred antibodies to their babies, but only a few children developed their own antibodies later—2.1% for Chlamydia and 0.4% for Mycoplasma at three years old. Understanding how these antibodies work can help improve care for children born to mothers with these infections. Who this helps: This helps doctors and health professionals working with expectant mothers and young children.

Plain English
This study looked at how the Epstein-Barr virus (EBV) affects oral human papillomavirus (HPV) infections in young children. Researchers followed 283 children from birth to three years old and found that most (91.4%) lost their mother's antibodies to EBV within about 11 months. Interestingly, it was noted that higher levels of paternal education were linked to lower EBV infection rates in children, and kids with higher initial levels of certain EBV antibodies had a significantly greater risk of both getting and clearing oral HPV infections. Who this helps: This research helps parents and healthcare professionals understand the relationship between EBV and HPV infections in children, potentially guiding future health strategies for preventing related cancers.

Plain English
The study investigated how the Epstein-Barr virus (EBV) affects the persistence of oral human papillomavirus (HPV) infections in men over three years. Among the 119 men studied, nearly all (99.2%) were found to have EBV. Those with higher levels of certain EBV antibodies had a significantly increased risk of continuing oral HPV infections, with some specific types of HPV showing more than a fourfold greater likelihood of persistence. This research is important because it helps us understand how having multiple viral infections can influence the stability of HPV, which is linked to throat cancers. Who this helps: This benefits men at risk of HPV-related health issues, including throat cancer, and may inform doctors on managing viral infections.

Plain English
This study looked at men living with HIV and how the presence of antibodies against a particular type of human papillomavirus (HPV16) relates to the risk of oropharyngeal cancer, which affects the throat. They found that men with HPV16 E6 antibodies had a 14 times greater chance of developing oropharyngeal cancer compared to those without these antibodies. Specifically, 45% of the cancer cases studied had these antibodies, while only 6% of controls did. Who this helps: This research benefits men living with HIV by improving understanding of their cancer risks.

Plain English
This study looked at how well dried blood spot (DBS) cards can detect antibodies for the human papillomavirus type 16 (HPV16) in patients with oropharyngeal squamous cell carcinoma (a type of throat cancer). Researchers found that DBS cards accurately identified HPV16 antibodies, with a sensitivity of 90% and perfect specificity of 100% for the E6 antibody, making them a viable and cost-effective option for testing in areas with limited medical resources. This matters because it provides a simpler way to test for a virus that can lead to cancer, especially in regions that struggle with healthcare access. Who this helps: This helps patients in underserved areas who may need better access to cancer screenings.

Plain English
This study looked at how infections from Mycoplasma genitalium (Mg) and human papillomavirus (HPV) interact in couples. The researchers followed 329 women and their 135 male partners over three years and found that women with high levels of antibodies to Mg were more likely to develop new oral HPV infections, with a risk increase of over four times (OR 4.14). Additionally, having these antibodies was linked to a greater likelihood of being positive for high-risk HPV after follow-up, with odds ranging from about 2.66 to 4.62. Who this helps: This research helps patients, especially women, understand the potential risks of HPV related to Mycoplasma genitalium infections.

Plain English
Researchers developed a new blood test using advanced DNA sequencing to detect HPV-associated head and neck cancers early, before symptoms appear, and compared it to three other blood-based detection methods. The new sequencing test detected cancer 98.7% of the time it was present and correctly identified healthy people 98.7% of the time—significantly better than existing blood tests. This breakthrough matters because HPV-related head and neck cancers are becoming more common, yet doctors currently have no way to catch them early when treatment is most effective.

Plain English
This study looked at the rates of bacterial vaginosis (BV) and sexually transmitted infections (STIs), including human papillomavirus (HPV), among 779 pregnant women in Ethiopia who showed no symptoms. It found that 26.8% of these women had either BV or an STI, and 22.1% tested positive for a high-risk type of HPV, which can lead to serious health issues like infertility or cervical cancer. This is important because it highlights the need for better screening and treatment to protect the health of mothers and their babies in areas with limited healthcare. Who this helps: This helps pregnant women, particularly those in low-access healthcare settings.

Plain English
This study looked at how the body’s immune responses to specific bacterial proteins relate to different stages of colorectal conditions, including cancer and polyps. Researchers found that certain antibody responses, like IgA to a protein called CagA, were linked to a lower risk of advanced adenoma (with an odds ratio of 0.48), while IgG levels to other proteins were associated with a higher risk for advanced adenomas and polyps (for example, an odds ratio of 2.46 for HpaA). Understanding these relationships could help in early detection and monitoring of colorectal issues, which is important for improving patient outcomes. Who this helps: This research benefits patients at risk for colorectal cancer and their healthcare providers.

Plain English
This study looked at how antibodies to certain herpesviruses relate to symptoms people experience during and after COVID-19. Researchers found that high levels of antibodies to Epstein-Barr virus (EBV) increased the chances of feeling very tired during COVID-19 by more than four times and were linked to ongoing fatigue later. Similarly, high levels of antibodies to Cytomegalovirus (CMV) raised the risk of having concentration problems and a reduced sense of taste after the illness by more than three times. These findings suggest that infections from these viruses might influence the symptoms some people face when they get COVID-19 or in the months that follow. Who this helps: This helps patients who are experiencing lingering COVID-19 symptoms, particularly those related to fatigue and concentration issues.

Plain English
This study looked at how getting vaccinated against human papillomavirus (HPV) affects the risk of developing certain high-risk HPV types in HIV-negative men who have sex with men (MSM). Among the 82 men studied, those who received the HPV vaccine were less likely to have active HPV infections (20.7%) compared to those who did not get vaccinated, who were much more likely to show signs of infection (almost 80%). This finding is important because it suggests that vaccination may help reduce the risk of anal cancer in this group, potentially allowing some vaccinated individuals to avoid unnecessary follow-up tests. Who this helps: This benefits HIV-negative men who have sex with men and healthcare providers managing their care.

Plain English
This study looked at genetic factors associated with head and neck cancers by analyzing data from over 19,000 patients and nearly 39,000 healthy individuals. Researchers found 29 new genetic variations linked to these cancers and discovered that one specific variant reduces the risk of developing head and neck cancer by 40%. This research is important because it helps us understand how genetics and lifestyle factors like smoking and drinking influence cancer risk in different populations. Who this helps: This benefits patients at risk for head and neck cancer and their doctors by providing better risk assessment and potential targets for prevention strategies.

Plain English
This study focused on creating standard reference materials for testing antibodies against Chlamydia trachomatis, a common sexually transmitted infection. Researchers screened blood samples from women aged 20 to 40 and pooled those that tested positive and negative for specific Chlamydia proteins to create a panel of candidate reference reagents. These new materials are essential because they will help laboratories provide more consistent and reliable test results for Chlamydia infections. Who this helps: This benefits doctors and laboratories by improving the accuracy of Chlamydia testing.

Plain English
This study looked at how common human papillomavirus (HPV) is among women in Ethiopia who are receiving prenatal care. They found that about 33% of the 783 women tested were positive for HPV, with urban women having a significantly higher rate (36.8%) than those from rural areas (17.6%). This is important because high levels of HPV can lead to cervical cancer, especially in a country where rates of this cancer are already high, highlighting the need for better screening and vaccination programs. Who this helps: This research helps women in Ethiopia, particularly those in urban areas and during pregnancy, by emphasizing the importance of HPV screening and vaccination.